| DIAGNOSIS | SYMPTOMS | INFECTION PROCESS | TREATMENTS | LYME FACTS | DELUSIONAL FACTS |
| GENERAL INFORMATION | LABORATORY TESTS | STANDARD TREATMENTS | ADDITIONAL TREATMENTS |
|
|
LABORATORY TESTS |
|
UNDER CONSTRUCTION - MORE COMING NEXT! Based on my own Lyme and Chlamydia infection, my survey and statistical data collected from Morgellons afflicted, I must claim that 2/3 of the Morgellons afflicted are actually suffering from Lyme disease and its coinfections, and the remaining 1/3 had no or some typical Lyme symptoms, but disappointly they had a seronegative result. But this fact is well known that Lyme disease very often does not show usual clinical findings. This can happen with Borrelia and many other pathogens which are not always present in the bloodstream, because they are already located intracellularly or incapsulated as cystic forms somewhere in the connective tissue or have changed their surface proteins. If you have heavy cough, pneumonia and cystic fibrosis-like symptoms and a lot of mucous is coming up, then this can be caused not only by Borrelia bacteria but also by enterobacteria as E. coli, Klebsiella oxytoca which could be carried from borrelia bacteria leaving the guts and entering the blood system and so on. At least you should test all the "pneumoniae" variants of pathogens which may cause lung issues. If you want to prove any fungal infection, if culturing did fail, also an automated fluorescent amplified fragment length polymorphism (AFLP) method can be used to examine fungal DNA. An immunofluorescent test can also detect a fungus if usual cultures did fail. Another bacterial & fungal Identification could be done by "Comparative 16s rDNA Sequencing" The main pathogens appearing with Morgellons or Lyme disease are listed below. |
|
What pathogens should be tested! |
|||
| Bacteria | Fungus | Protozoa | Virus |
| Anaplasma | Aspergillus | Babesia | Adeno-Virus |
| Bartonella | Candida | Plasmodium sp. | Cytomegalo (CMV) |
| Chlamydia | Common Molds | Toxoplasma | Epstein-Barr (EBV) |
| Lyme-Borrelia | Entomopathogenic fungi | Hepatitis A-B-C Virus | |
| Mycoplasma | Microsporidia | MLV-XMRV | |
| Treponema pallidum |
- | - | - |
| What else to test? | |
| Full blood profile (CBC) | |
| Hormonal level (Thyroids, DHT) | |
| Cortisol, Dopamin, ACTH, DHEA | |
| Lower testosterone/estrogen level | |
| HPA profile | |
| C-Reactive protein | |
| Homocystein, Albumin and iron level | |
| Red blood cell count | |
| ACE levels and Calcitonin | |
| Electrolyte balance | |
| Diabetes mellitus | |
| Sputum respiratory tract and function | |
| Eye infection and function | |
| Gastro-intestinal infection | |
| Urological infection | |
| Laboratory diagnostics
Laboratory diagnostics of the Borrelia infection, requested by a physician experienced with Lyme disease, are always indicated when a patient's complaints or clinical findings are compatible with a Lyme infection. Serological testing results, for the purpose of evaluating the success of therapy, are not meaningful for chronic Lyme, therapy success must be judged clinically. Under strictly scientific criteria, the cultural proof of Borrelia infection can only be demonstrated through pathogen DNA-identification by polymerase chain reaction (PCR) methods. The proof of Borrelia DNA by means of PCR nuclear confirmation is likewise of high importance. Borrelian serology is the basis diagnostic for the question of whether a Borrelia infection could be present; however the testing methods presently on the market, the enzyme-linked immunosorbent assay (ELISA) and immunoblot (Western blot) a test for immunoglobulins, or antibody proteins, signified by the initials IgG and IgM, are not standardized. Therefore, findings from these two methods can be compared only at the lowest common standards among them, and crossreactions caused from other pathogens with similar cell surface proteins can happen! The investigation of the presence of Borrelia-specific antibodies is possible only by means of immunoblot. With suspicion of one Borrelia infection, the IgG and IgM immunoblot Borrelia test should be required in all cases. The laboratory to which samples are referred must be required to express results in Borrelia serology inclusive of immunoblot for Borrelia. Even so, these tests can show negative results that do not exclude a true infection. One reason for a negative result can be that the antigen spectrum in an immunoblot assay did not match identically the antigens found in ELISA results. Borrelia ELISA and immunoblot are two different test methods, which correlate to a considerable degree with one another, but with different results in some cases. Negative serology does not exclude a present Borrelia infection, and even in the absence of antibodies, the need for treatment must be considered urgent. Seronegativity can be caused by early but inadequate antibiotic treatment, therapies with immunosuppressants, higher cortisol levels, exhaustion of the immune system, hidden pathogens, and a genetic disposition. On the other hand, positive serological findings just mean that the patient acquired a Borrelia infection somewhere, at some point, with older infections evidenced by IgG and more recent ones by IgM. It is not possible to decide whether this infection is latent or active by a unique serological investigation. That can be decided only by the treating physician on basis of an individual patient's clinical process and symptoms. The table below shows different Borrelia protein antigens/antibodies which can be detected by serology. |
|
Protein antigen |
Antigen description of antibodies | Specifity | Description |
|
p14, 18 |
- | highly specific | Known from B. afzelii as immunogenic |
|
p19 |
OspE (outer surface protein E) | unknown | - |
|
p21 |
DbpA (Decorin binding protein A) | highly specific |
Decorin binding protein particulary on skin and tissue cells of the host |
|
p22, 23, 24, 25 |
Osp C (outer surface protein C) | highly specific |
Most important IgM response marker of an early infection stage. Known are 13 different OspC-types |
|
p26 |
OspF (outer surface protein F) | unknown | - |
|
p29 |
OspD (outer surface protein D) | highly specific | - |
|
p31 |
OspA (outer surface protein A) | highly specific |
Known are 7 different OspA-types which defines different species |
|
p34 |
OspB (outer surface protein B) | highly specific |
Antibody appears more in a later infection stage |
|
p39 |
BMPA (Borrelia membrane protein A) | highly specific |
Antibody appears more in an early infection stage |
|
p41 |
Flagellin-protein | unspecific |
Primary and early appearing IgM antibodies. Cross-reactions with other kinds of spirochete and bacteria with flagella are possible |
|
p58 |
- | highly specific | - |
|
p60 |
Hsp6 | unspecific |
Antibodies which often might be present also with other bacterial infections |
|
p66 |
Hs | unspecific |
Antibody reaction to any bacterial infection |
|
p75 |
Hsp (heat shock protein) | unspecific | - |
|
p83, 100 |
- | highly specific |
Antibodies mainly present in a later infection stage |
|
VlsE |
VMP (variable major protein) like sequence expressed | highly specific |
VlsE protein is expressed only in the host. IgG-Antibodies might be present already in an early infection stage. |
|
What can you do if tests were seronegative? These pathogens can be encapsulated into human tissue by created cysts, to avoid detection and measurements and to survive there inside the cysts for a prolonged time, and also therefore no clinical results or antigens can be found and also no antibodies have been created from the immune system to detect and fight pathogens. Same situation can happen with the cell wall deficiency Borrelia forms! Don`t dispair, this can happen very often and an experienced physician based upon the symptoms will prescribe you then the right medication. If you don`t have any insurance or medical assistance, many sufferers reported us that they have ordered medications over online pharmacies. Please take care, many companies sell just fake drugs and without any physician you might not come further to treat such heavy infections! Check below different tests to detect Lyme disease. |
| Common Tests for Lyme Disease and Coinfections: | ||
| Bowen | The Bowen test might be only an alternative along with other tests using the Bowen Q-RIBb (Quantitative Rapid Identification of Borrelia). Bowen testing is not a validated method approved by FDA to diagnose Lyme disease. Don`t use it, there are many contraddictions using this test. | |
| CD-57 | The CD-57 subset or CD-57 counts measures a specific subset of the natural killer cells (NK-cells) when Lyme is active. The CD-57 count is suppressed only by Borrelia. It is not used as a diagnostic tool, but as marker to reflect the degree of Lyme infection. You can run the test at the beginning of a therapy and repeat it a few months later to determine the effectiveness of any treatment. Low CD 57 occurs in chronic Lyme or when the disease has been active for over one year. Below 20 indicates a heavy infection. 0-60 is typical for chronic Lyme disease. Above 60 indicates an improvement, and the counts of 200 indicates a normal condition or no infection. | |
| Chemokine-CXCL13 | CXCL13 is measured in cerebrospinal fluid (CSF) and serum and it is an important disease activity marker related to B-cells and the chemoattractant CXCL13 e.g. in acute neuroborreliosis. It is also an important mediator in the inflammatory cascade associated with the polyspecific intrathecal B cell and the humoral immune response in the pathogenesis and diagnosis of multiple sclerosis (MS) that manifests itself by MRZR reaction (response to neurotropic viruses) | |
| ELISA | Enzyme-Linked Immunosorbent Assay test for the presence of a specific protein using antibodies in the test kit. The protein is produced from the activation of the introduced DNA. | |
| IgM | IgM (Immunoglobulin M) is a basic antibody that is produced by B cells. It appears as first antibody in response to an initial exposure to an antigen. IgM antibodies are mostly present during an acute stage of infection. Done by Western Blot or ELISA | |
| IgG | IgG (Immunoglobulin G) antibodies are mainly present as secondary immune response after an older or longer ongoing infection. They correspond to a maturation of the antibody response. Done by Western Blot or ELISA | |
| LTT-MELISA | Lymphocyte-Transformation-Test have been applied to detect specific cellular immune reactivity of lymphocytes, the natural killer cells (B-cells, T-cells). The clinical application of LTTs is due to the poorly defined Borrelia antigens and nonstandardized LTT formats questionable. | |
| PCR | Polymerase Chain Reaction test for the presence of a specific DNA sequence, which must be recorded in the DNA-database and prepared in reference material. | |
| T-Cellspot (Elispot) | It measures the cellular defence (T-Cells) and shows an exposition in intracellular stages, newer or older infection. Elispot test method is not approved by FDA and still disputable but good as second diagnostic tool. | |
| Western Blot | Western blotting (IgM/IgG) is a technique used to identify and locate proteins based on their ability to bind to specific antibodies. It can analyze any protein sample whether from cells or tissues. | |
| LABORATORIES | ADVANCED LABS (T-cell spot, ELISA) | http://www.advanced-lab.com |
| IGENEX (Western blot IgM/IgG) | http://www.igenex.com | |
| FRYLABS (PCR, Western Blot IgM/IgG) | http://www.frylabs.com/staff.php | |
| LabCorp (CD-57, Western Blot IgM/IgG) | https://www.labcorp.com | |
| Pharmasan Labs (Western Blot, ITT, Cytokines) | http://www.pharmasan.com | |
![]()
| GENERAL INFORMATION | LABORATORY TESTS | STANDARD TREATMENTS | ADDITIONAL TREATMENTS |
| DIAGNOSIS | SYMPTOMS | INFECTION PROCESS | TREATMENTS | LYME FACTS | DELUSIONAL FACTS |
|
© COPYRIGHT M-R-O 2006 - 2012 ALL RIGHTS RESERVED |
|
ALL TEXTS AND PICTURES ARE THE PROPERTY OF M-R-O. YOU MAY COPY AND PUBLISH THEM IF YOU ASK FIRST M-R-O |
|
FOR PERMISSION TO INSURE ALL RIGHTS AND THE RESPECT FOR THE AUTHOR !! SITES WHICH ARE SELLING OR PROPAGADING |
|
PRODUCTS OR ABUSING MY CONTENT FOR OBSCURE PURPOSES ON THEIR PAGES ARE NOT ALLOWED TO COPY FROM M-R-O !!! |
| THANKS A LOT THE AUTHOR MARC NEUMANN. |